American Journal of Clinical Pathology

cancer cell international

omics : a journal of integrative biology

progress in transplantation (aliso viejo, calif)

Cytopathology : official journal of the British Society for Clinical Cytology

[1] Management of Thyroid Nodules in Deceased Donors With Comparison Between Fine Needle Aspiration and Intraoperative Frozen Section in the Setting of Transplantation.

[2] Mapping the Molecular Basis and Markers of Papillary Thyroid Carcinoma Progression and Metastasis Using Global Transcriptome and microRNA Profiling.

[3] ultrasonographic features of papillary thyroid carcinomas according to their subtypes

[4] il13rα2 sirna inhibited cell proliferation, induced cell apoptosis, and suppressed cell invasion in papillary thyroid carcinoma cells

[5] thyroid metastasis from breast carcinoma accompanied by papillary thyroid carcinoma

[6] Hobnail subtype of papillary carcinoma of the thyroid-a rare case with uncommon features.

[7] Novel design of NIR-triggered plasmonic nanodots capped mesoporous silica nanoparticles loaded with natural capsaicin to inhibition of metastasis of human papillary thyroid carcinoma B-CPAP cells in thyroid cancer chemo-photothermal therapy.

[8] High BRAFV600E mutation frequency in Chinese patients with papillary thyroid carcinoma increases diagnostic efficacy in cytologically indeterminate thyroid nodules.

[9] Medullary Thyroid Carcinoma and Papillary Thyroid Carcinoma in the Same Patient as a Collision Tumour

[10] Massive hemoptysis: an unusual presentation of papillary thyroid carcinoma due to tracheal invasion.

[11] Complex management decisions in a woman with concurrent primary hyperparathyroidism and metastatic papillary thyroid carcinoma, both presenting during pregnancy.

[12] The effect of TP53 and P21 gene polymorphisms on papillary thyroid carcinoma susceptibility and clinical/pathological features.

[13] Letter to the Editor regarding the article "Impact of extranodal extension on risk stratification in papillary thyroid carcinoma".

[14] Mapping the Molecular Basis and Markers of Papillary Thyroid Carcinoma Progression and Metastasis Using Global Transcriptome and microRNA Profiling.

[15] Serum antithyroglobulin antibody levels are not a good predictive factor on detection of disease activity in patients with papillary thyroid carcinoma

[16] Application of Magnetic-Resonance-Spectroscopy-Based Metabolomics to the Fine-Needle Aspiration Diagnosis of Papillary Thyroid Carcinoma

[17] Serum antithyroglobulin antibody levels are not a good predictive factor on detection of disease activity in patients with papillary thyroid carcinoma

[18] papillary carcinoma occurrence in a thyroglossal duct cyst with synchronous papillary thyroid carcinoma without cervical lymph node metastasis: two-cases report

[19] papillary thyroid carcinoma in ovarian strumal carcinoid tumor: case report

[20] ultrasonographic features of papillary thyroid carcinomas according to their subtypes

[21] il13rα2 sirna inhibited cell proliferation, induced cell apoptosis, and suppressed cell invasion in papillary thyroid carcinoma cells

[22] prognosis of multifocal papillary thyroid carcinoma

[23] prognosis of patients with papillary thyroid carcinoma located in one lobe showing lateral node metastasis in the contralateral but not ipsilateral compartment

[24] extended antitumor responseof a braf v600e papillary thyroid carcinoma to vemurafenib

[25] thyroid metastasis from breast carcinoma accompanied by papillary thyroid carcinoma

[26] clinicopathological characteristics and prognosis of papillary thyroid carcinoma in naturally menopausal women with various durations of premenarche, reproductive periods, and postmenopausal stages

[27] papillary thyroid carcinoma arising in children and adolescent hashimoto’s thyroiditis: ultrasonographic and pathologic findings

[28] clinical significance and prognostic impact of subcutaneous or intrastrap muscular recurrence of papillary thyroid carcinoma

[29] to identify predictors of central lymph node metastasis in patients with clinically node-negative conventional papillary thyroid carcinoma

[30] association between tumor size and bilateral involvement in papillary thyroid carcinoma

[31] occult papillary thyroid carcinoma metastasis to the sacrum and the skull: an unusual presentation

[32] review of survival rates 20-years after conservative surgery for papillary thyroid carcinoma

[33] intraoperative cytology as an additional method for detecting papillary thyroid carcinoma

[34] femoral pathological fracture as the first clinical manifestation of papillary thyroid carcinoma in a primigravida

[35] pancreas as delayed site of metastasis from papillary thyroid carcinoma

[36] papillary thyroid carcinoma: does the association with hashimoto's thyroiditis affect the clinicopathological characteristics of the disease?

[37] Solid variant of papillary thyroid carcinoma: An analysis of 28 cases with current literature.

[38] Overexpression of HIF-2α, TWIST, and CXCR4 Is Associated with Lymph Node Metastasis in Papillary Thyroid Carcinoma

[39] Overexpression of HIF-2α, TWIST, and CXCR4 Is Associated with Lymph Node Metastasis in Papillary Thyroid Carcinoma

[40] Research Progress on the Immunological Correlation Between Papillary Thyroid Carcinoma and Hashimoto's Thyroiditis.